Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Peak Surgical, Inc. · Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

150 daysmedian FDA review time
266 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K103775PEAK SUCTION COAGULATORPeak Surgical, Inc.2011-05-271510
K102709PEAK PLASMABLADE PLUS TISSUE DISSECTION DEVICEPeak Surgical, Inc.2010-12-17880
K102029PEAK PULSAR II GENERATOR MODEL PS100-102Peak Surgical, Inc.2010-12-161500
K093695PEAK PLASMABLADE 3.OS TISSUE DISSECTION DEVICEPeak Surgical, Inc.2010-04-131340
K083415PEAK PLASMABLADE TNA TONSIL AND ADENOID TISSUE DISSECTION DEPeak Surgical, Inc.2009-06-051990
K082786PULSAR GENERATOR, PEAK PLASMABLADE; 4.0, NEEDLE, AND EXT TISPeak Surgical, Inc.2008-12-03711
K073057PULSAR GENERATOR, MODEL PS100-100, AND PEAK PLASMABLADE TISSPeak Surgical, Inc.2008-07-222660

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda